Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by QContinuum1on May 10, 2024 8:22am
89 Views
Post# 36033066

RE:TD and Virtu

RE:TD and Virtu
subaru1 wrote: Hold it down to ,08, i still don't understand why there is no more buyer at ,085 and ,09 and more, usually the market is ahead of the best to come. I think that Mr Pidduck has something to prove here. My expectation is that we should be around a $1,00 in 2 years but for that the revenue will have to be well over $100 millions and the EPS around ,07 to ,10.

Qrt1 - 12 millions  Eps 0
Qrt2 - 15 millions  Eps 0,005
Qrt3 - 17 millions  Eps 0,01
Qrt4 - 20 miillions Eps 0,02
-----------------------
Tot:Y/E 24: 54 miilions Eps 0,035

Qrt1 - 24 millions Eps 0,02
Qrt2 - 27 millions Eps 0,02
Qrt3 - 30 millions Eps 0,025
Qrt4 - 35 millions Eps 0,03
-----------------------
Tot:Y/E 25: 116 millions Eps 0,095


There are no buyers because the sector has been a dumpster fire for a number of years, LABS itself has not shown any positive and sustained upward trajectory and, given the SP, no one with deep pockets will care about LABS until there is a major announcement/move.

If profitiability is near certain, then the SP will move accordingly.  But no one is going to take a chance on a no name small fry outfit with a whole lot of maybes, could bes and should bes to their name.

LABS makes good on Germany and Brazil then the money will follow.  A nice share buyback wouldn't hurt either.
<< Previous
Bullboard Posts
Next >>